Baishan Jiang
Wuhan University(CN)Zhongnan Hospital of Wuhan University(CN)
Publications by Year
Research Areas
Protein Degradation and Inhibitors, Advanced Breast Cancer Therapies, Ubiquitin and proteasome pathways, Cancer-related Molecular Pathways, Catalytic C–H Functionalization Methods
Most-Cited Works
- → Pharmacological perturbation of CDK9 using selective CDK9 inhibition or degradation(2017)539 cited
- → Mapping the Degradable Kinome Provides a Resource for Expedited Degrader Development(2020)350 cited
- → Development of Dual and Selective Degraders of Cyclin‐Dependent Kinases 4 and 6(2019)255 cited
- → Homolog-Selective Degradation as a Strategy to Probe the Function of CDK6 in AML(2018)247 cited
- → MELK is not necessary for the proliferation of basal-like breast cancer cells(2017)194 cited
- → INK4 Tumor Suppressor Proteins Mediate Resistance to CDK4/6 Kinase Inhibitors(2021)156 cited
- → USP8 inhibition reshapes an inflamed tumor microenvironment that potentiates the immunotherapy(2022)144 cited
- → Discovery and resistance mechanism of a selective CDK12 degrader(2021)132 cited
- → ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer(2021)132 cited
- → Increased lysosomal biomass is responsible for the resistance of triple-negative breast cancers to CDK4/6 inhibition(2020)103 cited